These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol]. Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695 [No Abstract] [Full Text] [Related]
45. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation. Briones ER; Steiger D; Palumbo PJ; Kottke BA Mayo Clin Proc; 1984 Apr; 59(4):251-7. PubMed ID: 6708603 [TBL] [Abstract][Full Text] [Related]
46. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen]. Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744 [No Abstract] [Full Text] [Related]
47. Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia. Spence JD; Huff MW; Heidenheim P; Viswanatha A; Munoz C; Lindsay R; Wolfe B; Mills D Ann Intern Med; 1995 Oct; 123(7):493-9. PubMed ID: 7661492 [TBL] [Abstract][Full Text] [Related]
48. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. Superko HR; Greenland P; Manchester RA; Andreadis NA; Schectman G; West NH; Hunninghake D; Haskell WL; Probstfield JL Am J Cardiol; 1992 Jul; 70(2):135-40. PubMed ID: 1626496 [TBL] [Abstract][Full Text] [Related]
49. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. Stein EA; Heimann KW S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650 [TBL] [Abstract][Full Text] [Related]
50. Increased plasma cholesterol esterifying activity during Colestipol resin therapy in man. Clifton-Bligh P; Miller NE; Nestel PJ Metabolism; 1974 May; 23(5):437-44. PubMed ID: 4825300 [No Abstract] [Full Text] [Related]
51. Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia. Fellin R; Briani G; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G Atherosclerosis; 1975; 22(3):431-45. PubMed ID: 1201145 [TBL] [Abstract][Full Text] [Related]
52. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia. Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203 [TBL] [Abstract][Full Text] [Related]
53. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia. Kuo PT; Hayase K; Kostis JB; Moreyra AE Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338 [TBL] [Abstract][Full Text] [Related]
54. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia. Grundy SM; Mok HY J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472 [TBL] [Abstract][Full Text] [Related]
55. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. Blankenhorn DH; Nessim SA; Johnson RL; Sanmarco ME; Azen SP; Cashin-Hemphill L JAMA; 1987 Jun; 257(23):3233-40. PubMed ID: 3295315 [TBL] [Abstract][Full Text] [Related]
56. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. Kinosian BP; Eisenberg JM JAMA; 1988 Apr; 259(15):2249-54. PubMed ID: 3127607 [TBL] [Abstract][Full Text] [Related]
57. Bile acid sequestrants and cholesterol. Schon P N Z Med J; 1990 Apr; 103(887):163. PubMed ID: 2111529 [No Abstract] [Full Text] [Related]
58. Hypocholesterolemic activity of colestipol hydrochloride in SEA quail. Day CE Artery; 1989; 17(1):49-59. PubMed ID: 2589993 [TBL] [Abstract][Full Text] [Related]
59. Colestipol therapy and selected vitamin and mineral levels in children. Nutr Rev; 1980 Jul; 38(7):236-7. PubMed ID: 7422147 [No Abstract] [Full Text] [Related]